28m
PDS Biotechnology Corp (PDSB) reports a solid cash position amid increased R&D expenses and promising clinical trial updates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback